Saturday, March 04, 2006


Viral Hepatitis C - Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C


Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 15 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin Anti-Viral in the treatment of chronic hepatitis C virus infection .Save to My Web

Viral Hepatitis C - HEPATITIS C INFECTION IN PATIENTS UNDERGOING HEPATIC


HEPATITIS C INFECTION IN PATIENTS UNDERGOING HEPATIC
HEPATITIS C INFECTION IN PATIENTS UNDERGOING HEPATIC RETRANSPLANTION (ReTx). It has been suggested that recurrent hepatitis C infection may bc associated with particularly poor outcome

The National AIDS Treatment Advocacy Program
Current treatment for hepatitis C infection. Hepatitis C - Frequently Asked Questions Basic Facts About Hepatitis A, B, and C How you can contract it; Functions of the liver

Diagnosis of Hepatitis C
Several tests for diagnosing hepatitis C infection are available, but since the levels of virus and the liver enzymes fluctuate, one

Friday, March 03, 2006


Viral Hepatitis C - Genotyping - HCV News Articles


Genotyping - HCV News Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and experimental vaccines for Hepatitis C.

Hepatitis C Information & Fact Sheets
Information and resources on hepatitis C, treatments, procedures, transmission and prevention of hepatitis C.

Hepatitis C: Index | CDC Viral Hepatitis
HIV/HCV Co-infection Center of Excellence: a national resource on HIV/HCV co-infection for clinicians and health professionals. StopHep. ...

Viral Hepatitis C - Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral


Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral
Medical News Today - Peregrine Pharmaceuticals, Inc. (PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in

Vertex Pharmaceuticals
Forbes - Deutsche Bank Securities initiated coverage of Vertex Pharmaceuticals with a "buy' rating and said the development-stage drug company's promising experimental drug candidate VX-950 has "gold standard" potential as a hepatitis C treatment. "Despite a

Third Wave, Chiron, Bayer dismiss HCV patent suit
Reuters UK - CHICAGO (Reuters) - Third Wave Technologies Inc. on Thursday said it reached an agreement with Chiron Corp. and Bayer Corp. to dismiss its lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV. Terms of the agreement were

Aethlon Medical Expands Device Pipeline to Include the Treatment of
Genetic Engineering News - Aethlon Medical plans to combine the core principles of its Hemopurifier platform technology with intellectual property developed by researchers at Boston University as a means to help prevent the spread of cancer following surgery. When cancer has

People With Chronic Hepatitis B To Benefit From Guidance On New Drugs
Medical News Today - The National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B. The guidance states that : - - - - Peginterferon alfa-2a is

Viral Hepatitis C - ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis


ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
... LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals ...

USDA Funded Projects
... as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample ...

Viral Hepatitis
... viralh epatitis viral ehpatitis viral hpeatitis viral heaptitis viral heptaitis viral hepaittis viral hepattiis viral ...

HBV SC()
... type chronic viral heaptitis B. World J Gastroenterol 2002;8:868-871 ...

Thursday, March 02, 2006


Viral Hepatitis C - What is Hepatitis C?(NC)-Hepatitis C is an infectious

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Viral Hepatitis C - Viral Hepatitis


Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Viral Hepatitis C - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Wednesday, March 01, 2006


Viral Hepatitis C - The National Institutes of Health (NIH) Consensus Development Program: Management of Hepatitis C: 2002


The National Institutes of Health (NIH) Consensus Development Program: Management of Hepatitis C: 2002
... The hepatitis C virus (HCV) is one of the leading known causes of liver disease in the United ... are believed to have been infected with HCV. Following the identification of ...

Hepatitis C - Wikipedia, the free encyclopedia - Translate this page
... The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the ...

HCV Homepage - Translate this page
Private Home Page of Hans C. VEIT Vienna/Austria ... HighRes. HCV.AT. Master Index ... In a famous Wine Village. Wenckebachgasse. Copyright HCV 2005 ...

International Blood Factor Litigation
Manufacturers allegedly sold blood factor contaminated with HIV and Hepatitis C. Includes information on the lawsuit for the victims.

Viral Hepatitis C - SCH 503034 Jumps on the Fast Track


SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Liver Cancer, Hepatitis C Connection Gets Clearer
Title: Liver Cancer, Hepatitis C Connection Gets ClearerCategory: Health NewsCreated: 12/8/2005 1:59:00 AMLast Editorial Review: 12/8/2005 1:58:50 AM

Tuesday, February 28, 2006


Viral Hepatitis C - Hepatitis Information Network: Hepatitis C


Hepatitis Information Network: Hepatitis C
News, epidemiology, natural history, and notes on the management and treatment of the disease.

WebMD: Hepatitis C Topic Overview
... What are the symptoms of hepatitis C infection? In cases of acute infection, young children usually have no ... What are the symptoms of hepatitis C infection? Who is affected by ...

Hepatitis C
... Over time, hepatitis C infection can lead to liver cancer, liver failure or cirrhosis ... Normally, hepatitis C infection produces no signs or symptoms during its earliest ...

Hepatitis C definition - Hepatitis C health and medical information produced by doctors
... At least half of HCV patients develop chronic hepatitis C infection. Diagnosis is by blood test ...

Monday, February 27, 2006


Viral Hepatitis C - Medscape Resource Center - Hepatitis C


Medscape Resource Center - Hepatitis C
Chronic Hepatitis C Virus Management: 2000-2005 Update from Ann Pharmacother. 2006;40(1):74-82.

Hepatitis C Factsheet - Liver Health Information - The American Liver
However, there is a low prevalence of the infection in long-term spouses of people with chronic hepatitis C virus who have no other risk factor for infection

Neumega May Have Role in Treatment of Chronic Hepatitis C
Neumega May Have Role in Treatment of Chronic Hepatitis C Researchers from the Brooke Army Medical Center in San Antonio have reported that Neumega (interleukin-11) may reduce hepatic inflammation

Viral Hepatitis C - Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and


Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

Special Features
NHPR - Snow Closings Get the latest snow closing information through this link to the WMUR website. Writers on a New England Stage A partnership between New Hampshire Public Radio and the Music Hall in Portsmouth, in collaboration with RiverRun Bookstore

Crown going ahead with tainted-blood trial
CTV - The Crown is proceeding with its criminal case against four doctors -- including the former head of the Canadian Red Cross -- and a U.S. company charged in the tainted-blood scandal. The trial finally got underway Tuesday, with all defendants

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Viral Hepatitis C - Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and


Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Sunday, February 26, 2006


Viral Hepatitis C - hbv_research


hbv_research
... 23-Oct-2002 Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B; 23-Oct-2002 Hepatitis C ...

Hepatitis C Infection
Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041. ... Coinfection HIV & Viral Heaptitis: a. guide. December 2003. ...

Hepatitis and Health news and miscellaneous communications ...
mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. liver Unit, Cathay General hospital,280 Sec.4,Jen-Ai Rd.,Taipei,Taiwan ...

[Immunohistochemical detection of hepatitis C virus antigen from ...
Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041. To investigate the infection of HCV and the expression of HCV antigen (HCAg) ...